학술논문

Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia August 2022 22(8):e751-e761
Subject
Language
ISSN
2152-2650